Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors

Endocrine

Volumn 47, Issue 1, 2014, Pages 177-182

  Fiore, Francesco ^a   Del Prete, Michela ^b   Franco, Renato ^a   Marotta, Vincenzo ^b   Ramundo, Valeria ^b   Marciello, Francesca ^b   Di Sarno, Antonella ^c   Carratù, Anna Chiara ^b   De Luca Di Roseto, Chiara ^b   Colao, Annamaria ^b   Faggiano, Antongiulio ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Interventional Unit Ultrasound   (Italy)

Author keywords

Chemoembolization; Embolization; Liver metastases; Neuroendocrine tumor

Indexed keywords

CISPLATIN; ETOPOSIDE; SOMATOSTATIN;

ABDOMINAL PAIN; ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ARTIFICIAL EMBOLISM; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; HUMAN TISSUE; HYPERTENSION; LEUKOCYTOSIS; LIVER METASTASIS; MALE; NAUSEA; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SAFETY; THROMBOCYTOPENIA; TRANSARTERIAL CHEMOEMBOLIZATION; TRANSARTERIAL EMBOLIZATION; TREATMENT RESPONSE; VERY ELDERLY; VOMITING; YOUNG ADULT; ADVERSE EFFECTS; CHEMOEMBOLIZATION; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; EVALUATION STUDY; GASTROINTESTINAL NEOPLASMS; LIVER NEOPLASMS; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PATHOLOGY; PROCEDURES; SECONDARY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906933823     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-013-0130-9     Document Type: Article

References (24)

1. E. Solcia et al., Natural history, clinicopathologic classification and prognosis of gastric ECL cell tumors. Yale J. Biol. Med. 71(3-4), 285-290 (1998)
2. A. Faggiano et al., Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: the NET management study. J. Endocrinol. Invest. 35(9), 817-823 (2012)
3. H. Chen et al., Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J. Am. Coll. Surg. 187(1), 88-92 (1998).; discussion 92-93
4. J.M. Sarmiento et al., Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J. Am. Coll. Surg. 197(1), 29-37 (2003)
5. D.S. Klimstra et al., The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems. Pancreas 39(6), 707-712 (2010)
6. J. Iwazawa et al., Transarterial chemoembolization with miriplatin-lipiodol emulsion for neuroendocrine metastases of the liver. World J Radiol 2(12), 468-471 (2010)
7. J.G. Touzios et al., Neuroendocrine hepatic metastases: does aggressive management improve survival? Ann. Surg. 241(5), 776-783 (2005).; discussion 783-785
8. A. Roche et al., Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur. Radiol. 13(1), 136-140 (2003)
9. C.G. Moertel et al., The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann. Intern. Med. 120(4), 302-309 (1994)
10. G.M. Mavligit et al., Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 72(2), 375-380 (1993)
11. C. Loewe et al., Permanent transarterial embolization of neuroendocrine metastases of the liver using cyanoacrylate and lipiodol: assessment of mid- and long-term results. AJR Am. J. Roentgenol. 180(5), 1379-1384 (2003)
12. S. Del Prete et al., Percutaneous ethanol injection of autonomous thyroid nodules with a volume larger than 40 ml: three years of follow-up. Clin. Radiol. 56(11), 895-901 (2001)
13. J. Qian, Interventional therapies of unresectable liver metastases. J. Cancer Res. Clin. Oncol. 137(12), 1763-1772 (2011)
14. H. Bergsma et al., Peptide receptor radionuclide therapy (PRRT) for GEP-NETs. Best Pract. Res. Clin. Gastroenterol. 26(6), 867-881 (2012)
15. H. Rajekar, K. Bogammana, R.S. Stubbs, Selective internal radiation therapy for gastrointestinal neuroendocrine tumour liver metastases: a new and effective modality for treatment. Int. J. Hepatol. 2011, 404916 (2011)
16. J. Nazario, S. Gupta, Transarterial liver-directed therapies of neuroendocrine hepatic metastases. Semin. Oncol. 37(2), 118-126 (2010)
17. F.T. Bosman, World Health Organization, International Agency for Research on Cancer, WHO classification of tumours of the digestive system, World Health Organization Classification of Tumours, 4th edn. (International Agency for Research on Cancer, Lyon, 2010), p. 417
18. R. Syha et al., Hepatocellular carcinoma: initial tumour response after short-term and long-interval chemoembolization with drug-eluting beads using modified RECIST. Eur. J. Gastroenterol. Hepatol. 24(11), 1325-1332 (2012)
19. T.J. Vogl et al., Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation. Eur. J. Radiol. 72(3), 517-528 (2009)
20. A.S. Ho et al., Long-term outcome after chemoembolization and embolization of hepatic metastatic lesions from neuroendocrine tumors. AJR Am. J. Roentgenol. 188(5), 1201-1207 (2007)
21. A.T. Ruutiainen et al., Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J. Vasc. Interv. Radiol. 18(7), 847-855 (2007)
22. P.P. Kamat et al., Hepatic arterial embolization and chemoembolization in the management of patients with large-volume liver metastases. Cardiovasc. Intervent. Radiol. 31(2), 299-307 (2008)
23. S. Gupta et al., Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience. Cancer J. 9(4), 261-267 (2003)
24. S.C. Pitt et al., Hepatic neuroendocrine metastases: chemo- or bland embolization? J. Gastrointest. Surg. 12(11), 1951-1960 (2008)